FDA establishes CBER safety council to strengthen postmarketing oversight of biological products
XLV•The FDA established a CBER Safety Council to review post-market safety signals and recommend regulatory actions for biological products.
XLV•The FDA established a CBER Safety Council to review post-market safety signals and recommend regulatory actions for biological products.
The council will report directly to the CBER director, operate separately from CBER product offices and coordinate with the CDC, NIH and international regulators.